News tagged with malignant brain cancer
A hijacking of healthy cellular circuits
Proteins that control cell growth are often mutated in cancer, and their aberrant signaling drives the wild proliferation of cells that gives rise to tumors. One such protein, the epidermal growth factor receptor (EGFR), ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Researchers discover brain cancer treatment using genetic material from bone marrow cells
In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of ...
Cancer
Apr 01, 2013 |
5 / 5 (1) |
0
|
Immortality gene mutation identifies brain tumors, other cancers
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research ...
Cancer
Mar 18, 2013 |
5 / 5 (3) |
0
|
Study identifies growth factor essential to the most common malignant pediatric brain tumor
A multi-institutional team led by Massachusetts General Hospital (MGH) researchers has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common ...
Cancer
Feb 28, 2013 |
not rated yet |
0
|
'Chemo brain': Study finds fog-like condition related to chemotherapy's effect on new brain cells and rhythms
(Medical Xpress)—It's not unusual for cancer patients being treated with chemotherapy to complain about not being able to think clearly, connect thoughts or concentrate on daily tasks. The complaint – ...
Neuroscience
Feb 21, 2013 |
not rated yet |
1
|
MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer
Between the blueprint of the genome and the products of its expression lie microRNAs, which can boost or lower the rate at which genes become stuff. In fact, many cancers use microRNA to magnify the expression of faulty genes ...
Cancer
Dec 13, 2012 |
5 / 5 (1) |
0
|
Research shows immune system response is detrimental to novel brain cancer therapy
For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor. ...
Cancer
Dec 04, 2012 |
not rated yet |
0
Using unique combination of diet and radiation therapy, researchers successfully destroy brain tumor cells
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy. The study, ...
Cancer
Dec 04, 2012 |
5 / 5 (1) |
0
|
For brain tumors, origins matter
(Medical Xpress)—Since stem cells and progenitor cells are regulated by different growth factors, brain tumors arising from these cells might respond differently to different therapies. Researchers at Sanford-Burnham ...
Cancer
Nov 13, 2012 |
not rated yet |
0
|
A sad legacy—Victims of childhood asbestos exposure
(Medical Xpress)—"Wittenoom kids" who spent their childhoods exposed to asbestos in the north-west of Western Australia are now developing a range of cancers or dying at a rate well above the average population, ...
Cancer
Sep 04, 2012 |
not rated yet |
1
Potential drug for treating deadly brain cancer
(Medical Xpress)—A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults − glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting ...
Cancer
Sep 04, 2012 |
5 / 5 (2) |
0
|
DNA deletions promote cancer, collateral damage makes it vulnerable
Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vul ...
Cancer
Aug 15, 2012 |
4.5 / 5 (2) |
0
|
Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival
An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Im ...
Immunology
Aug 15, 2012 |
5 / 5 (1) |
0
|
Study suggests new treatment target for glioblastoma multiforme
A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target ...
Cancer
Aug 01, 2012 |
5 / 5 (1) |
0
|
Better treatment for common childhood brain cancer
Children diagnosed with the most common paediatric malignant brain cancer, medulloblastoma, will benefit from more targeted treatment following the identification of genetic mutations in the cancer.
Cancer
Jun 26, 2012 |
not rated yet |
0
